NCT07450287 2026-03-04
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
Not yet recruiting
Clinical Trials
18 trialsNCT07373015 2026-01-28
Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase NA Not yet recruiting
NCT07366658 2026-01-26
NEUK203-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Not yet recruiting
NCT07102056 2025-12-29
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
First Affiliated Hospital of Zhejiang University
Not yet recruiting
NCT07274657 2025-12-10
SMILE
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase NA Not yet recruiting
NCT07258810 2025-12-02
ETP-NET
Hospices Civils de Lyon
Not yet recruiting
NCT07014254 2025-06-10
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Xijing Hospital
Phase NA Not yet recruiting
NCT06901856 2025-03-30
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Guangdong Provincial People's Hospital
Phase NA Not yet recruiting
NCT06764368 2025-01-08
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Beijing Chest Hospital
Phase 2 Not yet recruiting
NCT06607198 2024-09-23
PitNET2024
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT06485739 2024-07-03
Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase 4 Not yet recruiting
NCT06344832 2024-04-03
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
Peking Union Medical College Hospital
Not yet recruiting
NCT06300216 2024-03-08
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
Qilu Hospital of Shandong University
Not yet recruiting
NCT04889742 2023-12-26
HETERERO
Charite University, Berlin, Germany
Phase 2 Not yet recruiting
NCT05967481 2023-08-01
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Power Life Sciences Inc.
Not yet recruiting
NCT05894486 2023-06-08
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors
Peking University
Phase 2 Not yet recruiting
NCT04788927 2023-04-07
PPGL-Pred
Rigshospitalet, Denmark
Not yet recruiting
NCT05429216 2022-07-01
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Nanfang Hospital, Southern Medical University
Phase NA Not yet recruiting